quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:01:00·450d
PRRelease
Ascentage Pharma Group International logo
Ascentage Pharma Group International logo

Ascentage Pharma Announces Closing of U.S. Initial Public Offering

AAPG· Ascentage Pharma Group InternationalAAPGV· Ascentage Pharma Group International
Health Care
Original source

Companies

  • AAPG
    Ascentage Pharma Group International
    Health Care
  • AAPGV
    Ascentage Pharma Group International

Recent analyst ratings

  • Mar 12AAPGUpdateBTIG Research$48.00
  • Jan 13AAPGUpdateRodman & Renshaw$48.00
  • Dec 4AAPGUpdateOppenheimer$45.00
  • Nov 24AAPGUpdateTruist-
  • Nov 10AAPGUpdateBTIG Research$50.00
  • Nov 5AAPGUpdatePiper Sandler$48.00

Related

  • SEC1d
    SEC Form 6-K filed by Ascentage Pharma Group International
  • PR2d
    Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
  • INSIDER2d
    SEC Form 4 filed by Misra Veet
  • INSIDER2d
    SEC Form 3 filed by new insider Misra Veet
  • INSIDER3d
    Amendment: SEC Form 3 filed by new insider Cao Jin
  • SEC3d
    SEC Form 6-K filed by Ascentage Pharma Group International
  • PR4d
    Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
  • INSIDER13d
    SEC Form 3 filed by new insider Cao Jin
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022